SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (23489)10/11/2013 9:18:23 AM
From: Biotech Jim  Respond to of 23519
 
Looks like the Auxilium Canadian deal with Stendra is making the stock rise in premarket. Stock has been in the range of $10.50 and 11.12 so far this am. There will be a $15M milestone payment if the label is amended for its rapid onset of action, a differentiator compared to other erectile dysfunction drugs.



To: tom pope who wrote (23489)10/11/2013 11:56:33 AM
From: mopgcw  Read Replies (1) | Respond to of 23519
 
The scrips this week were up a little bit, and ARNA's were down a tad, but yes a jump would have been nice.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News